{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:13:55Z","timestamp":1790817235933,"version":"4.1.0"},"reference-count":67,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5,1]]},"DOI":"10.1210\/jc.2013-1172","type":"journal-article","created":{"date-parts":[[2013,3,30]],"date-time":"2013-03-30T01:34:11Z","timestamp":1364607251000},"page":"1971-1981","source":"Crossref","is-referenced-by-count":73,"title":["Teriparatide for Idiopathic Osteoporosis in Premenopausal Women: A Pilot Study"],"prefix":"10.1210","volume":"98","author":[{"given":"Adi","family":"Cohen","sequence":"first","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Stein","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert. R.","family":"Recker","sequence":"additional","affiliation":[{"name":"Department of Medicine (R.R.R., J.M.L., J.S.), Creighton University Medical Center, Omaha, Nebraska 68131;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Lappe","sequence":"additional","affiliation":[{"name":"Department of Medicine (R.R.R., J.M.L., J.S.), Creighton University Medical Center, Omaha, Nebraska 68131;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dempster","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology (D.W.D.), Columbia University Medical Center, New York, New York 10032;"},{"name":"Regional Bone Center (D.W.D., H.Z.), Helen Hayes Hospital, West Haverstraw, New York 10993;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[{"name":"Regional Bone Center (D.W.D., H.Z.), Helen Hayes Hospital, West Haverstraw, New York 10993;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Cremers","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Nickolas","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"M\u00fcller","sequence":"additional","affiliation":[{"name":"Institute for Biomechanics (R.M., A.Z.), ETH Zurich, 8093 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zwahlen","sequence":"additional","affiliation":[{"name":"Institute for Biomechanics (R.M., A.Z.), ETH Zurich, 8093 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Stubby","sequence":"additional","affiliation":[{"name":"Department of Medicine (R.R.R., J.M.L., J.S.), Creighton University Medical Center, Omaha, Nebraska 68131;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Shane","sequence":"additional","affiliation":[{"name":"Department of Medicine (A.C., E.M.S, S.C., D.J.M., T.L.N., P.Y., E.S.), New York, New York 10032;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113215353300_B1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00198-011-1560-y","article-title":"Premenopausal women with idiopathic low-trauma fractures and\/or low bone mineral density","volume":"23","author":"Cohen","year":"2012","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2011-1387","article-title":"Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis","volume":"96","author":"Cohen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B3","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1210\/jc.2012-1477","article-title":"Increased marrow adiposity in premenopausal women with idiopathic osteoporosis","volume":"97","author":"Cohen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrendo.2011.108","article-title":"Parathyroid hormone analogues in the treatment of osteoporosis","volume":"7","author":"Kraenzlin","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t2019041113215353300_B5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t2019041113215353300_B6","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113215353300_B7","first-page":"3069","article-title":"Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers","volume":"85","author":"Kurland","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B9","first-page":"475","article-title":"Bone quantification and dynamics of bone turnover","volume-title":"Principles and Practice of Endocrinology and Metabolism","author":"Dempster","year":"2002"},{"key":"key\n\t\t\t\t2019041113215353300_B10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02509542","article-title":"A microtomographic system for the nondestructive evaluation of bone architecture","volume":"58","author":"R\u00fcegsegger","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113215353300_B11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1359\/jbmr.1999.14.7.1167","article-title":"Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus","volume":"14","author":"Hildebrand","year":"1999","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/nme.2101","article-title":"A scalable multi-level preconditioner for matrix-free micro-finite element analysis of human bone structures","volume":"73","author":"Arbenz","year":"2008","journal-title":"Int J Numer Methods Eng"},{"key":"key\n\t\t\t\t2019041113215353300_B13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1359\/jbmr.2000.15.1.20","article-title":"The contribution of trabecular architecture to cancellous bone quality","volume":"15","author":"Dempster","year":"2000","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-008-0574-6","article-title":"Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women","volume":"19","author":"Syed","year":"2008","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jama.280.12.1067","article-title":"Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1\u201334): a randomized controlled trial","volume":"280","author":"Finkelstein","year":"1998","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113215353300_B18","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00198-009-0917-y","article-title":"Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status","volume":"20","author":"Langdahl","year":"2009","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113215353300_B20","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113215353300_B21","first-page":"1214","article-title":"Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis","volume":"84","author":"Finkelstein","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B22","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00198-010-1379-y","article-title":"Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide","volume":"22","author":"Blumsohn","year":"2011","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jbmr.238","article-title":"Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1\u201334)] in postmenopausal osteoporosis","volume":"26","author":"Cosman","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B24","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1210\/jc.2012-1262","article-title":"Skeletal histomorphometry in subjects on teriparatide or zoledronic acid therapy (SHOTZ) study: a randomized controlled trial","volume":"97","author":"Dempster","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1359\/jbmr.090315","article-title":"Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis","volume":"24","author":"Recker","year":"2009","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1359\/jbmr.070413","article-title":"Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis","volume":"22","author":"Chen","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B27","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B28","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S8756-3282(00)00316-1","article-title":"Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1\u201334) therapy in women with severe osteoporosis","volume":"27","author":"Hodsman","year":"2000","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113215353300_B30","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/03008200802412462","article-title":"Teriparatide following bisphosphonates: initial and long-term effects on microarchitecture and bone remodeling at the human iliac crest","volume":"50","author":"Jobke","year":"2009","journal-title":"Connect Tissue Res"},{"key":"key\n\t\t\t\t2019041113215353300_B32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jbmr.198","article-title":"Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate","volume":"25","author":"Misof","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF01625448","article-title":"hPTH 1\u201334 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses","volume":"1","author":"Reeve","year":"1991","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.bone.2006.06.007","article-title":"Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis","volume":"39","author":"Gallagher","year":"2006","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113215353300_B35","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-010-1376-1","article-title":"Variability in the measured response of bone to teriparatide","volume":"22","author":"Heaney","year":"2011","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t2019041113215353300_B36","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1210\/jc.2002-020334","article-title":"A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1\u201334)] with alendronate in postmenopausal women with osteoporosis","volume":"87","author":"Body","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B37","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113215353300_B38","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113215353300_B39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.bone.2004.12.008","article-title":"Bone histomorphometry in 22 male patients with normocalciuric idiopathic osteoporosis","volume":"36","author":"Ciria-Recasens","year":"2005","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113215353300_B41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1302\/0301-620X.40B3.420","article-title":"Osteoporosis of unknown cause in young people. Idiopathic osteoporosis","volume":"40B","author":"Jackson","year":"1958","journal-title":"J Bone Joint Surg Br"},{"key":"key\n\t\t\t\t2019041113215353300_B42","first-page":"2795","article-title":"Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men","volume":"82","author":"Johansson","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B43","first-page":"2799","article-title":"Insulin-like growth factor-I in men with idiopathic osteoporosis","volume":"82","author":"Kurland","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1359\/jbmr.2000.15.1.13","article-title":"Trabecular bone microarchitecture, bone mineral density, and vertebral fractures in male osteoporosis","volume":"15","author":"Legrand","year":"2000","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bone.2008.11.004","article-title":"Vertebral fractures are associated with increased cortical porosity in iliac crest bone biopsy of men with idiopathic osteoporosis","volume":"44","author":"Ostertag","year":"2009","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113215353300_B46","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00223-005-0158-9","article-title":"Osteoblast dysfunction in male idiopathic osteoporosis","volume":"78","author":"Pernow","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113215353300_B47","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00223-009-9239-5","article-title":"Bone histomorphometry in male idiopathic osteoporosis","volume":"84","author":"Pernow","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"key\n\t\t\t\t2019041113215353300_B48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jbmr.5650100812","article-title":"Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis","volume":"10","author":"Reed","year":"1995","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI115418","article-title":"Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation","volume":"88","author":"Marie","year":"1991","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113215353300_B50","first-page":"2792","article-title":"Idiopathic osteoporosis\u2014is the osteoblast to blame?","volume":"82","author":"Khosla","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B51","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/jbmr.100","article-title":"Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact","volume":"25","author":"Elis","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B52","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1210\/endo-127-4-1804","article-title":"Anabolic effect of human synthetic parathyroid hormone-(1\u201334) depends on growth hormone","volume":"127","author":"Hock","year":"1990","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113215353300_B53","first-page":"22","article-title":"Role of IGF-I on PTH effects on bone","volume":"33","author":"Lombardi","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t2019041113215353300_B54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1172\/JCI118121","article-title":"Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone","volume":"96","author":"Pfeilschifter","year":"1995","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113215353300_B55","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1359\/jbmr.070715","article-title":"PTH circadian rhythm and PTH target-organ sensitivity is altered in patients with adult growth hormone deficiency with low BMD","volume":"22","author":"White","year":"2007","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B56","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113215353300_B57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/9780470623992.ch63","article-title":"Premenopausal osteoporosis","volume-title":"Primer on the Metabolic Bone Diseases and Other Disorders of Bone and Mineral Metabolism","author":"Cohen","year":"2008","edition":"7th ed"},{"key":"key\n\t\t\t\t2019041113215353300_B58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11914-008-0007-7","article-title":"Treatment of premenopausal women with low bone mineral density","volume":"6","author":"Cohen","year":"2008","journal-title":"Curr Osteoporos Rep"},{"key":"key\n\t\t\t\t2019041113215353300_B59","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1210\/jc.2005-2827","article-title":"Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer","volume":"91","author":"Eng-Wong","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113215353300_B60","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","article-title":"Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women","volume":"14","author":"Powles","year":"1996","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113215353300_B61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen","year":"2006","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113215353300_B62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2010.02.018","article-title":"Should bisphosphonates be used in premenopausal women?","volume":"66","author":"Cohen","year":"2010","journal-title":"Maturitas"},{"key":"key\n\t\t\t\t2019041113215353300_B63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jwh.2008.0887","article-title":"Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center","volume":"18","author":"Cohen","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"key\n\t\t\t\t2019041113215353300_B64","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B65","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: a decade of experience","volume":"27","author":"Capriani","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B66","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1359\/jbmr.2001.16.5.925","article-title":"Parathyroid hormone added to established hormone therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal","volume":"16","author":"Cosman","year":"2001","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113215353300_B67","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1359\/jbmr.2000.15.5.944","article-title":"Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial","volume":"15","author":"Lane","year":"2000","journal-title":"J Bone Miner Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/5\/1971\/9047021\/jcem1971.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T15:09:41Z","timestamp":1562857781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/5\/1971\/2536963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,1]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2013-1172","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,1]]}}}